Lymphedema secondary to limited cutaneous systemic sclerosis. (15th June 2018)

• Record Type: Journal Article
• Authors: Moreira, Sónia; Crespo, Jorge; Santos, Lèlita
• Is Part Of: BMJ case reports. Volume 2018
• Publication Date: 2018-06-15
• Subjects: connective tissue disease -- dermatology; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2017-224148
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterised by vascular abnormalities, immune system activation and fibrosis. Lymphatic involvement in SSc was described more recently and starts in early stages. This report describes a 46-year-old patient who developed over the last 2 years asymmetric lymphedema in lower extremities. Compromise in lymphatic drainage was confirmed by lymphoscintigraphy. She also presented Raynaud's phenomenon, a scleroderma pattern in nailfold capillaroscopy, cutaneous thickening and anticentromere antibodies, which together resulted in a new diagnosis of limited cutaneous SSc. Treatment with methotrexate, prednisolone and lymphatic drainage resulted in lymphedema improvement. To our knowledge, this is the first case of grade 2 lymphedema in the setting of anticentromere-positive limited cutaneous SSc. We highlight the importance of considering rheumatic diseases in the differential diagnosis of lymphedema.